Genor Biopharma Releases Its Annual Results for 2020 – Arabian Post
Significant progresses in IND, clinical development, NDA/BLA, commercialization, BD and financing NDA/BLA progress – GB226 (Geptanolimab) Priority Review for ...
Significant progresses in IND, clinical development, NDA/BLA, commercialization, BD and financing NDA/BLA progress – GB226 (Geptanolimab) Priority Review for ...
Maharashtra, Kerala and Punjab together account for 76.4% of active COVID-19 cases currently, with Maharashtra alone contributing nearly 60%, ...
Copyright 2022 © BM Global News. Enjoy our Latest World News.